FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096387403> ?p ?o ?g. }

• W3096387403 abstract "Abstract To investigate the U2AF1 gene mutation site, mutation load and co-mutations genes in patients with myelodysplastic syndrome (MDS) and their effects on prognosis. Gene mutation detection by next-generation sequence and related clinical data of 234 MDS patients were retrospectively collected and analyzed for the relationship between the clinical characteristics, treatment efficacy and prognosis of U2AF1 gene mutation. Among the 234 MDS patients, the U2AF1 gene mutation rate was 21.7% (51 cases), and the median variant allele frequency was 39.5%. Compared with the wild type, the U2AF1 mutant had a higher incidence of chromosome 8 aberration, and was positively correlated with the occurrence of ASXL1 , RUNX1 , SETBP1 gene mutation, negatively correlated with SF3B1, NPM1 genes mutation ( p < 0.05). The most common mutation site of U2AF1 was S34F (32 cases), while U2AF1 Q157P site mutations had a higher incidence of chromosome 7 abnormalities ( p = 0.003). The U2AF1 gene mutation more frequently coincided with signal pathway related gene mutations ( p = 0.043) with a trend of shortened overall survival. Among patients with U2AF1 gene mutations, those with ASXL1 mutations were prone to develop into acute myeloid leukemia, those with RUNX1 mutations had an increased risk of relapse, and those with TET2 mutations had higher 1-year survival rate. Compared with the patient group of lower mutation load (VAF ≤ 40%), the group with higher mutation load of U2AF1 (VAF > 40%) had a significantly lower 1-year survival rate (46.1% and 80.5%, p = 0.027). The criteria of U2AF1 VAF > 40% is an independent indicator for poor prognosis of MDS patients. VAF > 40% of U2AF1 is an independent factor of short OS in MDS patients. MDS patients with a mutation in the Q157P site of U2AF1 and a higher U2AF1 mutation load suggests poor prognosis, and co-mutated genes in U2AF1 can affect disease progression and prognosis." @default.
• W3096387403 created "2020-11-09" @default.
• W3096387403 creator A5001632689 @default.
• W3096387403 creator A5005371991 @default.
• W3096387403 creator A5009670906 @default.
• W3096387403 creator A5036395511 @default.
• W3096387403 creator A5038456558 @default.
• W3096387403 creator A5045483141 @default.
• W3096387403 creator A5050060968 @default.
• W3096387403 creator A5080113481 @default.
• W3096387403 creator A5088192232 @default.
• W3096387403 date "2020-10-29" @default.
• W3096387403 modified "2023-10-18" @default.
• W3096387403 title "Differential U2AF1 mutation sites, burden and co-mutation genes can predict prognosis in patients with myelodysplastic syndrome" @default.
• W3096387403 cites W1489375841 @default.
• W3096387403 cites W1836050415 @default.
• W3096387403 cites W1993236149 @default.
• W3096387403 cites W2026134786 @default.
• W3096387403 cites W2091242855 @default.
• W3096387403 cites W2094395093 @default.
• W3096387403 cites W2305091941 @default.
• W3096387403 cites W2339658711 @default.
• W3096387403 cites W2377402344 @default.
• W3096387403 cites W2463367156 @default.
• W3096387403 cites W2469280064 @default.
• W3096387403 cites W2504187847 @default.
• W3096387403 cites W2556487299 @default.
• W3096387403 cites W2566723262 @default.
• W3096387403 cites W2753382695 @default.
• W3096387403 cites W2767026883 @default.
• W3096387403 cites W2792389485 @default.
• W3096387403 cites W2939230875 @default.
• W3096387403 cites W2947545033 @default.
• W3096387403 cites W2990446149 @default.
• W3096387403 cites W2992415557 @default.
• W3096387403 cites W2995975012 @default.
• W3096387403 cites W3000594265 @default.
• W3096387403 cites W3001584947 @default.
• W3096387403 cites W3005329625 @default.
• W3096387403 cites W3013431094 @default.
• W3096387403 cites W3029812548 @default.
• W3096387403 doi "https://doi.org/10.1038/s41598-020-74744-z" @default.
• W3096387403 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7596495" @default.
• W3096387403 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33122737" @default.
• W3096387403 hasPublicationYear "2020" @default.
• W3096387403 type Work @default.
• W3096387403 sameAs 3096387403 @default.
• W3096387403 citedByCount "12" @default.
• W3096387403 countsByYear W30963874032021 @default.
• W3096387403 countsByYear W30963874032022 @default.
• W3096387403 countsByYear W30963874032023 @default.
• W3096387403 crossrefType "journal-article" @default.
• W3096387403 hasAuthorship W3096387403A5001632689 @default.
• W3096387403 hasAuthorship W3096387403A5005371991 @default.
• W3096387403 hasAuthorship W3096387403A5009670906 @default.
• W3096387403 hasAuthorship W3096387403A5036395511 @default.
• W3096387403 hasAuthorship W3096387403A5038456558 @default.
• W3096387403 hasAuthorship W3096387403A5045483141 @default.
• W3096387403 hasAuthorship W3096387403A5050060968 @default.
• W3096387403 hasAuthorship W3096387403A5080113481 @default.
• W3096387403 hasAuthorship W3096387403A5088192232 @default.
• W3096387403 hasBestOaLocation W30963874031 @default.
• W3096387403 hasConcept C102306862 @default.
• W3096387403 hasConcept C104317684 @default.
• W3096387403 hasConcept C126322002 @default.
• W3096387403 hasConcept C143065580 @default.
• W3096387403 hasConcept C2483381 @default.
• W3096387403 hasConcept C2778729363 @default.
• W3096387403 hasConcept C2780007613 @default.
• W3096387403 hasConcept C2780817109 @default.
• W3096387403 hasConcept C2994225774 @default.
• W3096387403 hasConcept C30481170 @default.
• W3096387403 hasConcept C501734568 @default.
• W3096387403 hasConcept C502942594 @default.
• W3096387403 hasConcept C53226629 @default.
• W3096387403 hasConcept C54355233 @default.
• W3096387403 hasConcept C71924100 @default.
• W3096387403 hasConcept C86803240 @default.
• W3096387403 hasConcept C98638677 @default.
• W3096387403 hasConceptScore W3096387403C102306862 @default.
• W3096387403 hasConceptScore W3096387403C104317684 @default.
• W3096387403 hasConceptScore W3096387403C126322002 @default.
• W3096387403 hasConceptScore W3096387403C143065580 @default.
• W3096387403 hasConceptScore W3096387403C2483381 @default.
• W3096387403 hasConceptScore W3096387403C2778729363 @default.
• W3096387403 hasConceptScore W3096387403C2780007613 @default.
• W3096387403 hasConceptScore W3096387403C2780817109 @default.
• W3096387403 hasConceptScore W3096387403C2994225774 @default.
• W3096387403 hasConceptScore W3096387403C30481170 @default.
• W3096387403 hasConceptScore W3096387403C501734568 @default.
• W3096387403 hasConceptScore W3096387403C502942594 @default.
• W3096387403 hasConceptScore W3096387403C53226629 @default.
• W3096387403 hasConceptScore W3096387403C54355233 @default.
• W3096387403 hasConceptScore W3096387403C71924100 @default.
• W3096387403 hasConceptScore W3096387403C86803240 @default.
• W3096387403 hasConceptScore W3096387403C98638677 @default.
• W3096387403 hasFunder F4320321001 @default.
• W3096387403 hasFunder F4320323845 @default.
• W3096387403 hasIssue "1" @default.
• W3096387403 hasLocation W30963874031 @default.

• next